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a n a ly s i s Polygenic transmission disequilibrium confirms that common and rare variation act additively to create risk for autism spectrum disorders Autism spectrum disorder (ASD) risk is influenced by common polygenic and de novo variation. We aimed to clarify the influence of polygenic risk for ASD and to identify subgroups of ASD cases, including those with strongly acting de novo variants, in which polygenic risk is relevant. Using a novel approach called the polygenic transmission disequilibrium test and data from 6,454 families with a child with ASD, we show that polygenic risk for ASD, schizophrenia, and greater educational attainment is over-transmitted to children with ASD. These findings hold independent of proband IQ. We find that polygenic variation contributes additively to risk in ASD cases who carry a strongly acting de novo variant. Lastly, we show that elements of polygenic risk are independent and differ in their relationship with phenotype. These results confirm that the genetic influences on ASD are additive and suggest that they create risk through at least partially distinct etiologic pathways.
Risk for ASD is strongly genetically influenced and reflects several types of genetic variation [1] [2] [3] [4] [5] [6] [7] . Common polygenic variation, distributed across the genome, accounts for at least 20% of ASD liability 2, 5, 8, 9 .
De novo single-nucleotide and copy number variants can have a strong effect on the individuals who carry them 1, 3, 4 but account for less liability at a population level (<10%) 2 . Over the last several years, the common polygenic and de novo influences on ASD risk have been increasingly well characterized, particularly in terms of the distribution of their phenotypic effects. Most consistently, ASD-associated de novo variants have been strongly linked to intellectual disability, as well as other indicators of global neurodevelopmental impact (for example, seizures or motor delay) 1, 10 . Indeed, ASD-associated de novo mutations that yield protein truncations are far more commonly observed in global developmental delay than in autism itself 11 .
Recent studies have suggested that the common polygenic component of ASD has a different, perhaps surprising relationship with cognition. Polygenic risk for ASD has been positively associated with intelligence and educational attainment in several reports 6, [12] [13] [14] . In other words, in the general population, greater common variant risk for ASD is associated with higher IQ. These findings are difficult to interpret-on average, IQ in ASD is at least 1 s.d. below the population mean 1, 15 . Further, ASD share approximately 25% of their common variant influences with schizophrenia, and schizophrenia itself shows a negative genetic correlation with IQ 6, 14 . While genetic correlation analyses are not expected to be transitive, this particularly complex network of common variant associations has led to concerns about confounding resulting from ascertainment and case heterogeneity 16 .
Here we attempt to clarify the influence of common variant risk for ASD and to better understand the subgroups of individuals with ASD for whom polygenic variation contributes to risk. We thus sought to employ a robust family-based design that would be immune to many of the potential confounders that can arise in attempting to construct a well-matched case-control comparison. To advance this analysis, we extended the transmission disequilibrium approach to encompass polygenic risk scores; we call the resulting methodology the polygenic transmission disequilibrium test (pTDT). Using pTDT, we then show that common polygenic predictors of (i) ASD, (ii) schizophrenia, and (iii) years of educational attainment are unambiguously associated with ASD risk, independently of the presence of intellectual disability in cases. We find that common polygenic variation still contributes to ASD risk in cases that carry a very deleterious de novo event. Lastly, we find that the three aforementioned polygenic risk factors have independent and distinct effects on phenotypic heterogeneity in ASD, suggesting that components of common polygenic variation also behave additively and operate through at least partially distinct etiological pathways.
Children are expected to inherit half of their parents' risk alleles for a trait. This expectation forms the basis of several commonly used tests of genetic association. The classic transmission disequilibrium test, for example, examines the frequency with which single genetic variants are transmitted from parents to their children 17 . Variants transmitted significantly more than half of the time from unaffected parents to children affected with some trait or condition (over-transmitted variants) are nominated for association with that trait-only ascertainment on the basis of a trait in the offspring and the association of the allele with the trait introduce deviation from the 50/50 chance of inheriting either allele from a heterozygous parent. Transmission disequilibrium tests have several convenient properties. First, they are immune to confounding by ancestry. They are also less vulnerable to bias from other potential differences between cases and controls, such as socioeconomic background or other factors commonly related to case ascertainment, as the 'controls' are in effect the perfectly matched untransmitted chromosomes.
In this study, we extend the transmission disequilibrium test to polygenic risk scores and introduce the polygenic transmission A full list of authors and affiliations appears at the end of the paper. disequilibrium approach. A polygenic risk score (PRS) provides a quantitative measure of an individual's genome-wide common variant predisposition (or 'risk') for a trait (Online Methods). PRSs are normally distributed in the population, which means that some degree of common variant risk for complex traits like ASD is present in all individuals. As a child has a 50% chance of inheriting either allele from a heterozygous parent, it is algebraically defined that the expected value of a child's PRS for any trait will be equal to the average of their parents' PRSs (mid-parent PRS). This expectation is broken when offspring are specifically ascertained for phenotypic deviation from their parents (Supplementary Fig. 1 ), for example, children who are much taller than their parents or are affected with ASD when their parents are not. In the example of ASD, we would then expect the affected child to have received more of their parents' ASD risk alleles than expected by chance 9 . From this expectation, the average offspring PRS for an ASD-associated trait would be greater than the average mid-parent PRS. By comparing ASD individuals' PRSs for various traits against those of their unaffected parents, one can unambiguously associate specific types of common variant risk (for example, polygenic risk for schizophrenia and educational attainment) with ASD and query the subsets of cases in which those risk factors are most relevant.
We used two independent ASD family cohorts to examine transmission of polygenic risk (Online Methods and Supplementary Table 1) . The Simons Simplex Collection (SSC) is a resource of more than 2,500 families with a single child diagnosed with ASD 18 . No other family members to the level of first cousins had an ASD diagnosis. Genotype data were available for the parents, the affected child, and an unaffected sibling for 2,091 SSC families (quad families). An additional 493 SSC families had available data for the parents and the affected child alone (trio families). Most genotyped individuals in SSC were exome sequenced in previous studies (89.0%) 4 . Our independent Psychiatric Genomics Consortium ASD (PGC ASD) sample consisted of 3,870 genotyped parent-child trios from the Psychiatric Genomics Consortium Autism Group (Supplementary Table 2 ). The PGC ASD cohort described here does not include individuals from the SSC, and the data set does not include exome sequence information.
We calculated common polygenic risk for ASD, educational attainment, and schizophrenia for all genotyped family members in the SSC and PGC ASD data sets using a standard approach (Online Methods) 19 . In addition to polygenic risk for ASD itself, we chose to examine polygenic risk for educational attainment and schizophrenia, as those phenotypes have been most strongly linked to ASD in genome-wide genetic correlation studies 6, 14, 20 . To build the polygenic predictors, we used summary statistics from the largest independent genomewide association studies (GWAS) of each phenotype (Supplementary Table 3 ). The discovery GWAS (including for ASD) did not include any SSC or PGC ASD individuals. Using the calculated PRSs, we first examined properties of their distribution in the parents. Analyzing the SSC and PGC ASD cohorts separately, we did not observe any consistent correlations between the parents' PRSs for any pair of PRSs and, on the basis of this, no PRS-based evidence of assortative mating (Supplementary Tables 4 and 5, and Supplementary Note). We also found no evidence that the mothers and fathers of children with ASD differed with regard to the common variant risk that they carried (Supplementary Table 6 and Supplementary Note). Lastly, there was no evidence that mid-parent polygenic risk differed by proband sex (Supplementary Table 7 and Supplementary Note).
The pTDT is a t test asking whether the mean of the offspring PRS distribution is consistent with its parentally derived expected value (Online Methods). In brief, for each trio, one averages the parent PRSs for a given trait to generate the mid-parent value and then subtracts that value from the proband's PRS for the same trait. To standardize and improve interpretability, we divide the resulting difference by the standard deviation of the (observed) mid-parent distribution. This yields the estimated pTDT deviation, and the pTDT then tests whether the average pTDT deviation across all offspring differs from zero. A mean pTDT deviation of 0.1 for the ASD PRS, for example, would indicate that the offspring's ASD PRS is on average 0.1 s.d. higher than that of their parents.
RESULTS

Polygenic transmission disequilibrium
For ASD, schizophrenia, and educational attainment, we calculated the average pTDT deviation for each affected child in the SSC and PGC ASD cohorts, as well as for each unaffected sibling in the SSC. The primary pTDT results are shown in Figure 1a . In both the SSC and PGC ASD samples, polygenic risk for ASD, educational attainment, and schizophrenia was significantly over-transmitted to affected children (P < 1 × 10 −6 for all comparisons), but not to SSC unaffected siblings (P > 0.05 for all comparisons; Fig. 1a ). This means that common polygenic risks defined in GWAS of ASD, schizophrenia, and greater educational attainment are each unambiguously associated with ASD. The results did not change when the SSC and PGC ASD samples were restricted to families of European ancestry ( Supplementary Figs. 2 and 3, Supplementary Table 8 , and Supplementary Note). We repeated the analysis in the SSC and PGC ASD samples using a PRS for body mass index (BMI)-a polygenic risk category unassociated with ASD 6 -as a negative control (Online Methods). As expected, we found that neither ASD probands nor unaffected siblings over-inherited the BMI PRS (P > 0.05 for all comparisons) (Supplementary Table 9 ).
The degree of polygenic over-transmission did not differ between SSC and PGC ASD probands for any comparison (P > 0.05 for all comparisons; Supplementary Table 10), so we combined the samples to improve the power of subsequent subgroup analyses. Using the combined data, each PRS was over-transmitted to both male and female probands (P < 0.05 for all comparisons; Fig. 1b) . Each of the three PRSs was significantly and equally over-transmitted to ASD cases with measured IQs in the intellectual disability range (IQ < 70; Fig. 1c , Online Methods, and Supplementary Tables 11 and 12) when compared with those without intellectual disability. Most probands in the intellectual disability group did not have an observed genetic event that might explain their low IQ, for example, a de novo mutation from an ASD-associated class, and repeating the analysis in the low-IQ SSC probands with the carriers of de novo events removed did not change the observed associations (Online Methods and Supplementary Table 13 ).
Common and rare variant additivity
To best interrogate additivity between common polygenic and rare, strongly acting variation, we defined a group of de novo mutations of large effect (Supplementary Table 14) . We previously identified a subclass of de novo protein-truncating variants (contributing PTVs) responsible for almost all of the PTV association with ASD 21 (Online Methods). As de novo copy number variants (CNVs) that delete a gene should have the same, if not greater, molecular impact as a PTV in that gene, we were motivated to investigate whether we could similarly refine the association of ASD with de novo deletions (Online Methods). In the SSC, we found that ASD were strongly associated with de novo deletions from two categories: (i) deletions that included a constrained gene predicted to be intolerant of heterozygous a n a ly s i s a n a ly s i s a CDNV than their unaffected siblings; ASD probands with all three of these comorbid traits were approximately 15 times as likely (OR = 15.05; P = 9.08 × 10 −10 ) to carry a CDNV than their unaffected siblings. Because de novo events observed in cases and controls differ with regard to their average severity 23 , their effect size cannot be directly estimated using the case-control carrier ratio. Using the male: female carrier approach described by De Rubeis et al. 3 , we estimated that, on average, the CDNVs defined here conferred an approximately 20-fold increase in risk for an ASD diagnosis (Online Methods). Their effect size, however, likely varies, as the male:female ratio of the carriers declined with increasing count of neurodevelopmental comorbidities (Supplementary Table 16 ). In other words, CDNVs seen in individuals with ASD exhibiting multiple comorbid neurodevelopmental traits are likely, on average, more deleterious than those seen in probands with ASD alone.
loss-of-function variation (probability of loss-of-function intolerance (pLI) ≥ 0.9) 22 and (ii) uncommon, large (≥500-kb) deletions that did not contain a constrained gene (referred to hereafter as contributing CNV deletions; Supplementary Figs. 4 and 5) .
Together, these refined classes of de novo PTVs and deletions form a category of strongly acting de novo variants (referred to hereafter as contributing de novo variants (CDNVs); odds ratio (OR) = 3.91, P = 6.56 × 10 −20 ; case rate = 9.4%, control rate = 2.6%). Consistent with a hallmark of ASD-associated de novo variation, the rate of CDNVs in SSC varied substantially according to the probands' counts of cooccurring adverse neurodevelopmental outcomes, in this case the count of intellectual disability, a history of seizures, and the presence of delayed walking (Fig. 2a , Online Methods, and Supplementary  Table 15 ). ASD probands without any of these comorbid traits were more than three times as likely (OR = 3.15; P = 3.88 × 10 −10 ) to carry Figure 1 ASD probands over-inherit polygenic risk for ASD, schizophrenia, and greater educational attainment. Transmission disequilibrium is shown in terms of standard deviation on the mid-parent distribution ± 1.96 standard error (95% confidence intervals). P values denote the probability that the mean of the pTDT deviation distribution is 0 (two-sided, one-sample t test). (a) ASD probands over-inherit ASD-associated polygenic risk in the SSC (n = 2,584), PGC ASD (n = 3,870), and combined (n = 6,454) cohorts. Unaffected siblings in SSC (n = 2,091) do not over-inherit ASD-associated polygenic risk. (b) Both male (n = 5,490) and female (n = 962) probands over-inherit ASD-associated polygenic risk in the SSC + PGC ASD combined cohort. (c) ASD probands with (n = 1,341) and without (n = 2,743) intellectual disability (full-scale IQ < 70) over-inherit ASD-associated polygenic risk in the SSC + PGC ASD combined cohort. ASD, autism spectrum disorders; SCZ, schizophrenia; EA, educational attainment. a n a ly s i s
We used pTDT to determine whether polygenic risk for ASD, schizophrenia, and educational attainment was also over-transmitted to CDNV carriers ( Fig. 2b and Online Methods). ASD cases with a CDNV (n = 221 cases) indeed carried more polygenic risk for ASD and schizophrenia than expected on the basis of parent background (P < 0.05 for both comparisons). There was no evidence of overtransmission of the educational attainment PRS (P = 0.80), although a larger number of ASD cases with a CDNV will be required to differentiate a true null in this instance from an issue of power. Over-transmission of the ASD and schizophrenia PRSs provides clear evidence for additivity between common and rare variation in creating risk for ASD. We did not see a difference in polygenic over-transmission between probands with zero versus one or more co-occurring neurodevelopmental outcomes (P > 0.05 for all comparisons; Supplementary Table 17) , further supporting the consistent influence of polygenic risk factors.
Additivity among common polygenic risk factors
In the context of three orthogonal risk distributions, each of which is associated with ASD, one does not have to maintain an extreme position on any single distribution to carry a cumulatively uncommon amount of ASD risk (Fig. 3a) . For example, being in the top 20% of three uncorrelated ASD risk distributions would result in a cumulative amount of risk seen in less than 1% of people in the population (0.2 3 = 0.008).
Common polygenic risk for ASD, schizophrenia, and educational attainment is partially correlated 6 . However, we observed little evidence of correlation between the ASD, schizophrenia, and educational attainment PRSs in terms of either (i) correlation at the mid-parent level or (ii) correlation in the degree to which the scores were transmitted to the probands (pTDT deviation) (Fig. 3b) . The lack of strong associations is likely a function of both ascertainment effects and attenuation due to limited predictive ability of the PRSs.
Given the limited association between the three PRSs, we were able to examine additivity among largely distinct common polygenic risk factors. First, we saw significant evidence that each of the three PRSs was independently over-transmitted (P < 2 × 10 −4 in all SSC + PGC ASD comparisons; Online Methods and Supplementary  Table 18 ). This means that ASD risk is influenced by elements unique to each of the scores, as well as by elements that are shared among them. Independent influences are further suggested by the scores' relationships with proband IQ (Supplementary Table 19) . We determined the association between each PRS and full-scale proband IQ in European-ancestry SSC probands, controlling for sex, presence of CDNVs, the other two PRSs, and the first ten principal components of ancestry (Fig. 3c and Online Methods). The educational attainment and schizophrenia PRSs were associated with proband IQ in opposite directions, consistent with the patterns observed in the general population (Supplementary Table 19) 14 .
In addition to statistical evidence of unique contributions, the phenotypic associations suggest that the three PRSs are influencing ASD risk through at least partially different processes. Polygenic risk for schizophrenia influences ASD liability in a manner that negatively influences cognition, whereas polygenic risk for educational attainment influences ASD liability in a manner that positively influences cognition. These findings reinforce the idea that ASD heterogeneity is shaped not only by rare variants of strong effect but also by diverse common variant risk factors acting through multiple biological pathways. The OR was calculated via Poisson regression predicting CDNV count from case/control status for all controls (n = 1,736) and cases in the outcome category, controlling for maternal and paternal age at birth of the child. P values above each diamond are from the Poisson regression and indicate the probability that the CDNV rate in cases is not different from the CDNV rate in controls. P values between the diamonds were calculated by Poisson exact test and indicate the probability that there is no difference in CDNV rate between the two noted groups. Error bars, ±1 standard error. (b) pTDT analysis for SSC CDNV proband carriers (n = 221). Transmission disequilibrium is shown in terms of standard deviation on the mid-parent distribution ± 1.96 standard error (95% confidence intervals). P values denote the probability that the mean of the pTDT deviation distribution is 0 (two-sided, one-sample t test). a n a ly s i s association between ASD risk and the common polygenic influences on ASD themselves, schizophrenia, and greater educational attainment. These effects were evident in affected males and affected females, as well as ASD individuals with and without intellectual disability. Because of the strong correlation between the polygenic influences on educational attainment and intelligence 14 , this finding means that, on average, individuals with ASD and intellectual disability have inherited more IQ-increasing alleles than their typically developing siblings. This association, which replicated in independent ASD cohorts and held in probands without an ASD-associated de novo event, will require further study. With regard to proband phenotype, the finding furthers existing questions of whether an IQ measured below 70 in someone with ASD might be different in some ways from an IQ measured below 70 in someone without ASD. With regard to better understanding the mechanisms through which genetic risk is conferred, we need to examine how and when certain amounts of risk are beneficial (for example, a strong interest in the arts or sciences that increases one's educational attainment) and how and when they are deleterious (for example, an overwhelming interest in a topic that disrupts healthy and necessary activities). Genetic risk and phenotypic traits relevant to neuropsychiatric disease exist on continua 24 , which will likely need to be taken into account in effective research and treatment paradigms. These findings also highlight important differences between the common and rare variant contributors to ASD risk. Strongly acting, de novo variant risk for ASD has an impact on a limited subset of cases. The phenotypic preferences of these types of variants are now well established; they are associated with intellectual disability, seizures, and global neurodevelopmental impact 1 . Common variant risk factors, on the other hand, appear to be more pervasively influential among ASD cases. Common variant risk appears similarly relevant to ASD individuals with high and low IQ, and those with and without a strongly acting de novo mutation. The common polygenic influences also appear comparatively neurologically gentle. In fact, they are in many cases associated with better educational and cognitive outcomes in the population. These differences strongly suggest that de novo and common polygenic variation may confer risk for ASD in different ways. Particularly as common polygenic risk is the more consistent contributor to ASD liability across cases, it will be critically important to take common variation into account in creating animal or stem cell models of ASD.
DISCUSSION
The pTDT approach can be broadly used to interrogate and clarify polygenic relationships. As a family-based approach, pTDT is immune to ancestral stratification and is less likely to be confounded by other influences on case ascertainment, for example, socioeconomic status. While pTDT achieves optimal power in comparing offspring with parents, it can be easily adapted to compare probands and unaffected siblings, and its predictive ability will improve through additional methodological development and larger discovery sample sizes. A command line tool to assist with pTDT analysis is publically available (see URLs).
URLs. pTDT software, https://github.com/ypaialex/ptdt; Exome Aggregation Consortium (ExAC), http://exac.broadinstitute.org/; Psychiatric Genomics Consortium (PGC), https://www.med.unc. edu/pgc/results-and-downloads; Ricopili, https://sites.google.com/ a/broadinstitute.org/ricopili/home.
METhODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. . P values, which estimate the probability of no association between each PRS and IQ, were calculated from linear regression. We predicted full-scale IQ from each PRS, z normalized following residualization for the other two PRSs, CDNV presence/ absence, proband sex, and the first ten principal components of proband ancestry. Each panel displays the linear association between full-scale proband IQ and the normalized PRS. a n a ly s i s a n a ly s i s
ONLINE METhODS
Sample description. The analytic cohorts are presented in Supplementary  Table 1 . The research specific to this study was approved by the Partners Healthcare Institutional Review Board. The SSC is a resource of more than 2,500 families with a child diagnosed with an ASD 18 . Informed consent and assent were provided for all subjects. Each member of the family was genotyped on one of the following platforms: Illumina Omni2.5, Illumina 1Mv3, or Illumina 1Mv1 (ref. 1). We analyzed 2,091 SSC quads, defined as families with both parents, the proband, and a designated unaffected sibling genotyped, and 493 SSC trios, defined as families with both parents and the proband genotyped. Most SSC families were also whole-exome sequenced to detect rare coding variation (82.7% of quads, an additional 8.0% of quads without sibling sequencing; 91.1% of trios). The PGC ASD sample consisted of parent-proband trios from the Psychiatric Genomics Consortium Autism Group (Supplementary Table 2) . Our PGC ASD analytic sample excluded the SSC families present in the PGC ASD GWAS 20 . The PGC ASD sample described here is accordingly independent from the SSC sample and included 3,870 parent-proband trios. In brief, the PGC ASD data included ASD trio cohorts from the Autism Center of Excellence at UCLA (n = 215), the Autism Genome Project (n = 2,254), the Montreal/Boston Collection (n = 138), Johns Hopkins University (n = 764), and the Children's Hospital of Philadelphia (n = 499) 20 . All genotype data (SSC and PGC ASD) were imputed using the 1000 Genomes Project reference panel and Ricopili pipeline, which are publicly available and have been reported on extensively 19, 25 .
Although trio approaches are broadly immune to confounding through ancestry, we isolated European-only subsets of both the SSC and PGC ASD samples to (i) ensure that our primary results did not change in an ancestrally homogeneous subset of the data and (ii) conduct comparisons across probands or across parents, which might be sensitive to ancestry (as opposed to comparisons between the proband and parents in a trio). In the SSC, we first selected probands with parent-reported white, non-Hispanic ancestry (n = 1,912). We merged the genotype data from these individuals with the HapMap 3 data set 26 and generated principal components of ancestry using GCTA 27 . Through visual inspection (Supplementary Fig. 6 ), we defined an ancestrally European SSC subcohort, leaving 1,851 probands (and, by extension, 1,851 families). We calculated principal components of ancestry distinctly within the derived SSC European-ancestry subcohort and used these as covariates in the non-trio analysis (for example, genotype-to-phenotype analyses among probands).
Self-reported ancestry was not available for the PGC ASD samples. To conservatively isolate a European-ancestry PGC ASD subcohort, we identified families in which both parents were of European ancestry. To do so, we merged the PGC ASD parent data with HapMap 3 and similarly generated principal components of ancestry using GCTA. By visual inspection, we identified European-ancestry individuals, leaving 6,742 of the original 7,740 PGC ASD parents (Supplementary Fig. 7 ). Both parents were of European ancestry in 3,209 families, and these families comprised the European-ancestry PGC ASD subcohort. We again calculated principal components of ancestry within the derived PGC ASD European-ancestry subcohort for use as analytic covariates in non-trio analyses.
Polygenic risk scoring.
A PRS provides a quantitative estimate of an individual's genetic predisposition ('risk') for a given phenotype based on common variant genotype data and independent GWAS results for the target phenotype (for example, schizophrenia or educational attainment) 28 . The score provides a relative, not absolute, measure of risk. For example, individual A (PRS schizophrenia = 8) is at higher estimated genetic risk for schizophrenia than individual B (PRS schizophrenia = 6), but a PRS of 8 or 6 is not independently interpretable.
We calculated polygenic risk for ASD, educational attainment, schizophrenia, and BMI for all individuals with available genotype data in the SSC and PGC ASD data sets. To do so, we used summary statistics from the largest available, independent GWAS of each phenotype (Supplementary Table 3) . None of the subjects in the SSC or PGC ASD cohort were included in any of the four GWAS discovery samples. We selected schizophrenia and educational attainment because of their robust, well-replicated associations with ASD risk 6, 14, 20 . We selected BMI as a negative control because of its lack of association with ASD risk 6 . We used ASD summary statistics from a GWAS of a Danish population-based sample of 7,783 cases and 11,359 controls from the first ten genotyping waves of the iPSYCH-Broad Autism project 24 . The schizophrenia summary statistics were from the 2014 GWAS of 36,989 cases and 113,075 controls from the Psychiatric Genomics Consortium 19 . The educational attainment summary statistics were from a population-based GWAS of years of schooling (n = 328,917, discovery and replication meta-analysis, excluding 23andMe) 12 . The BMI summary statistics were from a populationbased GWAS of BMI (n = 322,154, European-ancestry meta-analysis) 29 .
To construct the PRSs, we first gathered the summary statistics from the GWAS described above. The summary statistics included effect sizes and P values for each SNP in the imputed GWAS analysis, typically approximately 10 million markers. We then employed the widely used Ricopili pipeline to generate the PRS 19 . In brief, Ricopili first removes SNPs within 500 kb of and correlated with (r 2 ≥ 0.1) a more significantly associated SNP in the GWAS. We used the 1000 Genomes Project reference panel to estimate SNP correlations 25 . This process typically reduces the SNP list to fewer than 300,000 markers. For complex, polygenic traits, only a small fraction of the SNPs remaining pass the genome-wide significance threshold of P = 5.00 × 10 −8 ; the majority of the signal resides in SNPs that do not pass the significance threshold and cannot be specifically identified 6, 12, 19, 27 . To maximally capture common polygenic influence, we therefore relaxed the P-value threshold for SNPs in the PRS until doing so added more noise than signal (threshold options: P ≤ 1, 5 × 10 −1 , 2 × 10 −1 , 1 × 10 −1 , 5 × 10 −2 , 1 × 10 −2 , 1 × 10 −3 , 1 × 10 −4 , 1 × 10 −6 , and 5 × 10 −8 ). We identified the optimal P-value threshold as that which explained the most phenotypic variation for each trait. For the ASD PRS, we found that the threshold of P ≤ 0.1 explained the most case-pseudocontrol variance in SSC (as the SSC does not have independent control data, we generated pseudocontrol genotypes from the untransmitted parental alleles) 20, 24 . For the schizophrenia and educational attainment PRSs, we used the thresholds identified by analyses accompanying the discovery GWAS as explaining the most variance 12, 19 . In the PGC's 2014 schizophrenia analyses, a P-value threshold of P ≤ 0.05 most commonly explained the most schizophrenia casecontrol variance in 40 leave-one-out analyses 19 . For educational attainment, constructing a PRS using a threshold of P ≤ 1 explained the most variance in the number of years of education achieved in an independent sample 12 . For BMI, constructing a PRS using a threshold of P ≤ 0.2 explained the most variance in phenotypic BMI among cases in the SSC (Supplementary Note). These thresholds created the strongest PRSs for ASD, educational attainment, schizophrenia, and BMI, leaving us maximally powered to investigate the relationship between these four traits and ASD.
Next, we excluded SNPs that were poorly imputed in either SSC or PGC ASD (info score < 0.6 in either cohort). The exception to this filtering rule was in SSC-specific analyses (for example, analysis of de novo variation) where our info threshold of 0.6 was the minimum in the SSC imputation only. For each trait, the PRS for individuals in SSC and PGC ASD was then calculated as the product of the GWAS effect size (log odds ratio or β value) at that SNP and the individual's count of reference alleles at that SNP (0, 1, or 2), summed across all remaining markers. We implemented this scoring protocol using the score function in PLINK 30 . If an individual was missing genetic data at a SNP in the summary statistics file, PLINK calculated the expected score on the basis of the cohort-wide allele frequency. ) is the standard deviation of the sample-specific mid-parent PRS. For example, in SSC analysis, SD(PRS MP ) was the standard deviation of the mid-parent PRS distribution in SSC parents. We chose to standardize the pTDT deviation to improve interpretability and to facilitate comparison between different PRSs. We standardized by PRS MP instead of PRS C because we expect the parent PRS distribution to be a better proxy for the population PRS distribution. The approach can be adapted to PRSs from unaffected siblings, but using mid-parent PRSs improves statistical power (Supplementary  Table 20 and Supplementary Note).
To evaluate whether the pTDT deviation was significantly different than 0, we defined the pTDT test statistic (t pTDT ) as t mean pTDT deviation
where n is the number of families included in the pTDT. We evaluated t pTDT as a two-sided, one-sample t test. We performed pTDT using the ASD, educational attainment, schizophrenia, and BMI PRSs described above in four groups: SSC probands (n = 2,584), SSC unaffected siblings (n = 2,091), PGC ASD probands (n = 3,870), and the combination of SSC and PGC ASD probands (n = 6,454). As described in the main text (Fig. 1a) , each of the ASD, educational attainment, and schizophrenia PRSs was significantly over-transmitted from parents to probands, but not to unaffected siblings (P < 1 × 10 −6 for all parent to proband comparisons in either SSC or PGC ASD; P < 1 × 10 −15 for all parent to proband comparisons in combined SSC and PGC ASD; P > 0.05 for all unaffected sibling comparisons). In contrast, the BMI PRS was not over-transmitted to probands (P > 0.05 in both the SSC and PGC ASD). In a complementary permutation test, we randomly assigned case and control labels to the affected and unaffected children in SSC. We then counted the number of times that the simulated difference in the ASD PRS between affected and unaffected SSC children exceeded the observed difference (86 of 1,000,000 permutations = 0.0086%), consistent with the primary results (those in Fig. 1a) .
In our primary associations ( Fig. 1a and Supplementary Table 8 ), there were no statistically significant pTDT differences between the SSC and PGC ASD cohorts (Supplementary Table 10 ). We accordingly combined SSC and PGC ASD for the analyses stratified by sex and IQ to increase statistical power (Fig. 1b,c) . In SSC, full-scale IQ (SSC variable: sscfsiq) was derived from a number of scales and available for almost all probands (99.8%). Those scales included but were not limited to the Differential Ability Scales, Second Edition 31 ; the Mullen Scales of Early Learning 32 ; and the Wechsler battery 33 . Our full-scale SSC IQ estimates were taken from the SSC's 'full-scale deviation IQ' variable when it was available and 'full-scale ratio IQ' when it was not 34 . Full-scale IQ was measured heterogeneously across the contributing PGC ASD cohorts (Supplementary Table 2 ). To accommodate measurement differences, full-scale IQ was converted to broad groups for PGC consortiumlevel analyses (for the most part, numeric IQ values from PGC ASD were not available for this analysis). PGC ASD probands were assigned full-scale IQ levels 1-4 as follows: 1, full-scale IQ < 35; 2, 35 ≤ full-scale IQ < 70; 3, 70 ≤ full-scale IQ < 90; 4, 90 ≤ full-scale IQ. In PGC ASD, 38.9% of probands had estimated IQ available. We categorized probands in SSC and PGC ASD separately by presence/absence of intellectual disability so that the data sets could be analyzed together (SSC ID, IQ < 70; PGC ASD ID, IQ = 1 or IQ = 2). We repeated the IQ-stratified analyses in SSC and PGC ASD separately, which further suggested no differences between the cohorts, despite the limited fullscale IQ data available in PGC ASD (Supplementary Tables 11 and 12 ).
De novo variant analyses. We defined a group of de novo mutations strongly associated with ASD risk (Supplementary Table 14) . We performed this analysis exclusively in SSC; we could not perform the analysis in PGC ASD because only common variant (GWAS) data were available. Our previous work has identified a subclass of de novo PTVs (frameshift variants, splice-acceptor variants, splicedonor variants, nonsense variants) that are a primary source of association with ASD 21 . De novo PTVs in this class are (i) absent from the Exome Aggregation Consortium database, a reference sample of over 60,000 exomes, and (ii) found within a gene predicted to be intolerant of heterozygous loss-of-function variation (probability of loss-of-function intolerance (pLI) ≥ 0.9) 22 . In the SSC, de novo PTVs in this class were found in 7.1% of cases and 2.1% of unaffected siblings (P = 4.12 × 10 −14 ). PTVs outside of this contributing class were unassociated with ASD risk (observed in 7.8% of cases and 6.9% of unaffected siblings, P = 0.50) and were not associated with proband IQ (P = 0.76) (Supplementary Fig. 8 ).
As detailed in the main text, de novo CNVs that delete a gene should have the same molecular impact as a PTV in that same gene. Contributing CNV deletions were seen in 2.5% of SSC cases and 0.5% of SSC unaffected siblings (P = 1.80 × 10 −8 ). All other types of de novo deletions were observed in 1.7% of cases and 1.4% of unaffected siblings and were not associated with ASD risk (P = 0.48; Supplementary Fig. 5 ). The associations between CNV categories and ASD risk did not differ substantially when controlling for parental age at birth of child (Supplementary Table 21) . Contributing deletions outside of our defined class were not associated with proband IQ (P = 0.34; Supplementary Fig. 9 ). In contrast, de novo duplications of constrained genes were not disproportionately associated with ASD risk (P = 0.49; Supplementary Fig. 10 and Supplementary Note).
We identified a subset of de novo CNV deletions, primarily those containing loss-of-function-intolerant genes, that accounted for most of the category's association with ASD (contributing CNV deletions; Supplementary Fig. 4) . Together, contributing PTVs and contributing CNV deletions formed a strongly acting de novo variant category in SSC, described herein as contributing de novo variants (CDNVs). Multiple lines of evidence suggest that CDNVs are robustly associated with ASD risk. CDNVs were seen in 9.4% of SSC cases (n = 221 of 2,346) that were both sequenced and genotyped and 2.6% of SSC unaffected siblings (n = 45 of 1,736) that were both sequenced and genotyped (P = 6.56 × 10 −20 ). CDNVs were very strongly associated with proband IQ (P = 5.80 × 10 −6 ; controlling for proband sex), while all other de novo PTVs and deletions (those not in the CDNV category) were not associated with proband IQ (P = 0.44, controlling for proband sex; Supplementary Fig. 11 ).
As de novo variants are on average more severe when observed in ASD cases than in controls 23 , we could not estimate the amount of ASD risk conferred by CDNVs directly from the case-unaffected sibling odds ratio. As noted in the main text, we used the male:female CDNV carrier ratio to re-estimate the effect size for the event class, as described in De Rubeis et al. 3 . In brief, the approximately 4:1 male:female ratio among ASD cases suggests a different ASD liability threshold for males and females in the population. Regardless of whether that difference reflects etiology or ascertainment, it results in a direct mathematical relationship between the expected effect size of an event class and the male:female carrier ratio of cases. In the case of CDNVs, a variant class observed twice as frequently in female probands as in male probands (17.4% versus 8.5%, P = 5.26 × 10 −6 ; Supplementary Fig. 12 ), we estimate an odds ratio of approximately 20 (ref. 3) . This estimate exceeds that directly suggested by the CDNV case-control excess of 3.63.
We next examined the rate of CDNVs in SSC probands based on the number of adverse proband co-occurring neurological and developmental outcomes (Fig. 2a) . Previous studies have demonstrated that de novo PTVs and de novo CNVs are both associated with intellectual disability (IQ < 70) in ASD probands and are positively associated with history of seizures 1, 15 . Motor delays are an additional neurodevelopmental comorbitidy associated with ASD 35 . Here we defined motor delay for SSC probands as walking unaided at or after 19 months, the age by which the great majority of children have begun to walk 10 . As hypothesized, motor delay, seizures, and low IQ were independently associated with CDNV rate in SSC probands after controlling for proband sex (Supplementary Ta ble 15 ). CDNV rate was positively associated with the number of these adverse outcomes experienced by probands (Fig. 2a  and Supplementary Table 16 ). The decreasing male:female ratio among CDNV carriers as the count of co-occurring neurodevelopmental outcomes increases suggests that with an increased count of neurodevelopmental comorbidities comes, on average, increasingly severe de novo events (Supplementary Table 16 and Supplementary Note). Multiple lines of evidence, including associations with IQ, male:female carrier ratio, and adverse co-occurring neurodevelopmental outcomes, suggest that CDNVs are strongly associated with ASD risk.
Using pTDT, we evaluated polygenic transmission in probands carrying at least one CDNV (Fig. 2b and Supplementary Table 13) . As this CDNV analysis is specific to SSC, the PRSs generated for the CDNV analysis used info score cutoffs from SSC imputation to increase the number of wellimputed SNPs retained for the PRSs. We restricted our analysis to families with genotyped parents and probands with both genotype and exome sequence data (n = 2,346; n = 221 with CDNVs). The cohort of probands with a CDNV
